Showing 1 - 10 of 453
Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal Joint Committee (G-BA). In case no head-to-head studies are available for direct...
Persistent link: https://www.econbiz.de/10010526947
Persistent link: https://www.econbiz.de/10009711019
Persistent link: https://www.econbiz.de/10010429797
Persistent link: https://www.econbiz.de/10011474668
Persistent link: https://www.econbiz.de/10014558790
Persistent link: https://www.econbiz.de/10000001457
significantly smaller in Germany, significantly larger in France, and does not differ significantly in the UK. The results for wages … services firms into exporting does not show up among firms from France and the UK where no statistically significant …
Persistent link: https://www.econbiz.de/10010286601
Persistent link: https://www.econbiz.de/10000886137
Persistent link: https://www.econbiz.de/10000869880
Persistent link: https://www.econbiz.de/10000836680